Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VINCENT N MUONEKE

Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery

NPI
1699712448
CMS profile
667806
Location
BURIEN, WA

General Payments · PY2018–2024

$56,200.52

  • Reported across 31 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$30,633.38

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $30,633.38 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $30,633.38 13

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $22.55 1
PY2019 $13.35 1
PY2020 $150.00 1
PY2022 $4,754.54 6
PY2023 $20,626.70 9
PY2024 $30,633.38 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137639718 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137639720 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137639722 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137639724 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,213.34 05/06/2024 Consulting Fee Undisputed 01/23/2026 1137639726 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137639728 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137639730 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137639732 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137639734 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137639736 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137639738 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137639740 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137639742 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.